Innovation in Market Access: winning approaches to secure commercial success
The Market Access function in pharmaceutical and other medical technology companies has reached a stage of maturity, and professionals now want to take a step back, explore best practices and identify the best approach to innovation.
Re-thinking the European Business Model Portfolio for the Digital Age
CEOs and Boards of Directors across the globe are struggling to understand how digitalization, the process of becoming a digital business, can be leveraged to achieve the growth they are seeking. However many of these same leaders are focusing primarily on operational efficiency and wonder why they are not seeing the growth results they desire. European business leaders must understand that expanding and diversifying their business model portfolio plays a significant role in realizing growth. In this report, we explain how to deliver on ambitious growth goals by business model innovation and how to move towards the new value-creative asset-light with a blended business model.
Will the new eIDAS standards help your business win market share?
Picture this familiar (Sisyphean) story. After a hard slog, it looks like you’re about to clinch a huge deal with a major European firm. You’ve pushed the mythical boulder up the mountainside. All that remains is for the client to sign on the dotted line, so you hurriedly dispatch the contract documents.
Can Europe be a player in the Platform Economy?
Is Europe missing out on the market potential of the platform economy?
Let’s be honest — the headline figures do not look good. Out of a total of USD 4.3 trillion globally, Europe can currently claim only 200 billion of market capitalisation — that is, less than 5%.